IPSC

0.5597

1.78% 0.0098

Handel nachbörslich: .55 -0.0097 -1.73%

Century Therapeutics Inc (IPSC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$0.5499

Offen:

$0.5499

24-Stunden-Volumen:

777.46K

Relative Volume:

1.06

Marktkapitalisierung:

$48.35M

Einnahmen:

$2.24M

Nettoeinkommen (Verlust:

$-136.67M

KGV:

-0.2444

EPS:

-2.29

Netto-Cashflow:

$-102.08M

1W Leistung:

+0.20%

1M Leistung:

+11.76%

6M Leistung:

+12.12%

1J Leistung:

-62.18%

1-Tages-Spanne:

$0.5236

$0.56

1-Wochen-Bereich:

$0.5236

$0.6175

52-Wochen-Spanne:

$0.3418

$1.83

Century Therapeutics Inc Stock (IPSC) Company Profile

Firmenname

Century Therapeutics Inc

Sektor

Healthcare (1140)

Branche

Biotechnology (636)

Telefon

215-981-4000

Adresse

25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA

Mitarbeiter

165

Twitter

Nächster Verdiensttermin

2025-03-19

Neueste SEC-Einreichungen

IPSC's Discussions on Twitter

Vergleichen Sie IPSC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IPSC Century Therapeutics Inc	0.5597	47.51M	2.24M	-136.67M	-102.08M	-2.29
VRTX Vertex Pharmaceuticals Inc	412.22	104.45B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	469.36	60.95B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	572.60	59.11B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	812.95	49.23B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.94	35.92B	4.56B	-176.77M	225.30M	-1.7177

Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-08	Eingeleitet	Rodman & Renshaw	Buy
2023-08-28	Herabstufung	JP Morgan	Overweight → Neutral
2022-12-27	Eingeleitet	Chardan Capital Markets	Buy
2022-10-31	Eingeleitet	Guggenheim	Buy
2022-10-10	Eingeleitet	Canaccord Genuity	Buy
2022-05-23	Eingeleitet	H.C. Wainwright	Buy
2022-05-12	Eingeleitet	William Blair	Mkt Perform
2021-07-13	Eingeleitet	BofA Securities	Buy
2021-07-13	Eingeleitet	JP Morgan	Overweight
2021-07-13	Eingeleitet	Piper Sandler	Overweight

Alle ansehen

Century Therapeutics Inc Aktie (IPSC) Neueste Nachrichten

07:17 AM

Century Therapeutics Inc. stock volume spike explainedTrade Analysis Report & Fast Momentum Entry Tips - newser.com

07:17 AM

06:30 AM

Century Therapeutics Inc. stock momentum explained2025 Support & Resistance & Stock Market Timing Techniques - newser.com

06:30 AM

05:58 AM

Is Century Therapeutics Inc. stock reversal real or fake2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com

05:58 AM

03:11 AM

Is Century Therapeutics Inc. stock positioned well for digital economyPortfolio Return Summary & Fast Gaining Stock Strategy Reports - newser.com

03:11 AM

02:10 AM

Can Century Therapeutics Inc. recover in the next quarterJuly 2025 Action & Momentum Based Trading Ideas - newser.com

02:10 AM

01:31 AM

How to manage a losing position in Century Therapeutics Inc.July 2025 Action & Fast Momentum Stock Entry Tips - newser.com

01:31 AM

12:35 PM

How Century Therapeutics Inc. stock trades before earningsWeekly Loss Report & Community Driven Trade Alerts - newser.com

12:35 PM

Oct 13, 2025

Will Century Therapeutics Inc. rebound enough to break evenJuly 2025 Final Week & Proven Capital Preservation Tips - newser.com

Oct 13, 2025

Is Century Therapeutics Inc. building a consolidation baseQuarterly Trade Report & Precise Trade Entry Recommendations - newser.com

Oct 13, 2025

Is now a turning point for Century Therapeutics Inc.July 2025 Opening Moves & High Conviction Buy Zone Alerts - newser.com

Oct 13, 2025

Applying chart zones and confluence areas to Century Therapeutics Inc.2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - newser.com

Oct 13, 2025

Oct 12, 2025

How to use a screener to detect Century Therapeutics Inc. breakoutsMarket Trend Review & Reliable Volume Spike Alerts - newser.com

Oct 12, 2025

We Think Century Therapeutics (NASDAQ:IPSC) Needs To Drive Business Growth Carefully - Yahoo Finance

Oct 12, 2025

Century Therapeutics (NASDAQ:IPSC) Upgraded by Wall Street Zen to Hold Rating - Defense World

Oct 12, 2025

Oct 10, 2025

Century Therapeutics Inc. stock outlook for YEARMarket Volume Report & Fast Exit/Entry Strategy Plans - newser.com

Oct 10, 2025

Does Century Therapeutics Inc. fit your quant trading modelJuly 2025 Outlook & Daily Growth Stock Investment Tips - newser.com

Oct 10, 2025

What the charts say about Century Therapeutics Inc. today2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - newser.com

Oct 10, 2025

Oct 09, 2025

Critical Analysis: Century Therapeutics (NASDAQ:IPSC) and TransCode Therapeutics (NASDAQ:RNAZ) - Defense World

Oct 09, 2025

Oct 08, 2025

Layoff Tracker: Novo’s Cuts Leave Dozens of Manufacturing Workers Jobless - BioSpace

Oct 08, 2025

There Is A Reason Century Therapeutics, Inc.'s (NASDAQ:IPSC) Price Is Undemanding - simplywall.st

Oct 08, 2025

Oct 06, 2025

How to escape a deep drawdown in Century Therapeutics Inc.July 2025 Update & Verified Momentum Stock Watchlist - newser.com

Oct 06, 2025

Analysts Set Century Therapeutics, Inc. (NASDAQ:IPSC) Price Target at $3.75 - Defense World

Oct 06, 2025

Oct 05, 2025

Century Therapeutics Inc. recovery potential after sell offMarket Activity Recap & Risk Controlled Stock Pick Alerts - newser.com

Oct 05, 2025

How to build a dashboard for Century Therapeutics Inc. stockJobs Report & Community Consensus Trade Signals - newser.com

Oct 05, 2025

Oct 03, 2025

Is Century Therapeutics Inc. stock ready for a breakoutMarket Risk Analysis & Fast Moving Trade Plans - newser.com

Oct 03, 2025

Why Century Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com

Oct 03, 2025

Oct 02, 2025